stockrowBiotricity Inc.
BTCY Healthcare Medical Devices
Biotricity Inc.’s revenue for fiscal 2026 (year ended March 2026) was $16.0 million, up 16.0% from fiscal 2025.
- Revenue
- +10.4%
- EPS
- −66.7%
- Free cash flow
- +235.8%
- Total debt
- +3.48%
Quarter to June 2026, against a year earlier
Follow BTCY
Alert me
Biotricity Inc. (BTCY) EV/Sales
As of 6 November 2026, Biotricity Inc. (BTCY) trades at a EV/Sales of 1.7×. Over the past ten years it has ranged from 0.0× (March 2019) to 84.3× (April 2019); the current reading is higher than 30% of that period. That is below the Medical Devices industry median of 2.8× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2026 | 2.1× | (11.24%) |
| FY2025 | 2.3× | (18.72%) |
| FY2024 | 2.9× | (33.31%) |
| FY2023 | 4.3× | (68.74%) |
| FY2022 | 13.7× | (49.61%) |
| FY2021 | 27.3× | 6.96% |
| FY2020 | 25.5× | (67.47%) |
| FY2019 | 78.4× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.8× | (14.51%) |
| Mar 2026 | 2.1× | (7.61%) |
| Dec 2025 | 2.2× | (14.70%) |
| Sep 2025 | 2.6× | 8.03% |
| 29 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| AEMD Aethlon Medical, Inc. compare | −2.7× |
| MODD Modular Medical, Inc. compare | n/m |
| ITOC iTonic Holdings Ltd. compare | n/m |
| IRIX IRIDEX Corporation compare | 0.2× |
| BTCY Biotricity Inc. | 1.7× |
| SINT SINTX TECHNOLOGIES, INC. compare | 2.6× |
| PETV PetVivo Holdings, Inc. compare | 19.7× |
| PAVM PAVmed Inc. compare | 189× |
| HSCS HeartSciences Inc. compare | 519× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)